Homework # 2 A2 Subsection Dr. Sandra Navarra USTFMS.

Slides:



Advertisements
Similar presentations
HIV & TB. Worldwide TB is the most important opportunistic infection in HIV patients – its the commonest killer. Around 20 million people worldwide are.
Advertisements

Key1 World Bank Training Program on HIV/AIDS Drugs Training Module 3 Selection and Quantification based on the World Bank document Battling HIV/AIDS: A.
24th June World Health Organization Clinical Staging, AIDS surveillance and Mortality in resource-poor settings a clinicians view of strategic information.
Clinical Manifestations of TB
Q4: Clinical Case Conference on Human Immunodeficiency Virus Chua, Kathleen S.
Review of HIV and Opportunistic Infections (OI) in Children
BORDERNETwork Training on Late Presenter Dr. med. Wolfgang Güthoff / Alexander Leffers, M.A.
Dr.Mohsen Meidani. INFECTIOUS MONONUCLEOSIS INCLUDING Dr.Meidani dr.Mohsen Meidani.
Acute Retroviral Syndrome
Approach to Pulmonary Manifestations of HIV/AIDS
Module 1: Overview of HIV Infection Unit 01.03: Natural History and Progression Of HIV Infection 1.
HIV 101 Review Evaluation Center for HIV and Oral Health Boston University School of Public Health Health & Disability Working Group.
The HIV virus. Committee on Oversight and Government Reform. HIV/AIDS Today, 1(1):1, January 18, 2008.
P AUL A LLYN, MD A FRICAN A MERICAN HIV U NIVERSITY U NIVERSITY OF C ALIFORNIA L OS A NGELES A UGUST 28, 2014.
Immune deficiency Diseases (2). Immune Deficiency Disorders Immunodeficiencies can be divided into primary immunodeficiency disorders, and secondary immunodeficiency.
In the name of God Fariba Rezaeetalab Assistant Professor.
Immunodeficiencies HIV/AIDS. Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may.
Diagnostic testing for HIV: The symptomatic patient.
AWARENESS OF HIV AIDS GIMANDA NAHDIAH DIANA B.11.1.
Adapted from curriculum by Tucson Interfaith HIV/AIDS Network
Diagnosing HIV UCLA AAHU Science and Treatment College Science Academy 2014.
Medical-Surgical Nursing: An Integrated Approach, 2E Chapter 23
Catalyst: Week 30 Class 1 1.In 2001, 92 rabbits were born, and 60 died. 14 rabbits immigrated to the area, and 17 emigrated from the area. Find the population.
DR.MOHAMMED ARIF ASSOCIATE PROFESSOR CONSULTANT VIROLOGIST HEAD OF THE VIROLOGY UNIT Cytomegalovirus (CMV)
Late presenters and opportunistic infections Jane Bruton Clinical Research Nurse Imperial College.
Chronic HIV Infection Clinical Manifestations Opportunistic Infections O.I. Prophylaxis.
HIV and AIDS: Protecting Yourself, Protecting Others David Lee, Mollie Williams, and Andrew Frankart.
The Silent Epidemic Any pathogen that spreads from one person to another during sexual contact is called a sexually transmitted infection, or STI. More.
Do Now Make two lists: one with a list of HIV symptoms and one with a list of AIDS symptoms. Make two lists: one with a list of HIV symptoms and one with.
 Heterosexual  Bi-sexual  Homosexual Blood and Blood Products  Blood transfusion  Tissue Transplantation e.g Kidney Transmission Modes for HIV (2)
Immunology, the HIV life cycle and stages of infection Anele Waters HIV Research Nurse North Middlesex Hospital, London.
Classification of HIV and Expanded AIDS Surveillance Case Definition.
Affordable healthcare Product Selection for Opportunistic Infections IDA HIV/AIDS Group, Nienke Gruppelaar “ HIV does not kill, opportunistic infections.
1 Respiratory Diseases in HIV-infected Patients HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Background There is uncertainty regarding the frequency, predictors, and outcomes of IRIS events Prior studies on IRIS have been limited to convenience.
Paul Allyn, MD African American HIV University University of California Los Angeles August 26, 2015.
1 Natural Course of HIV Infection HAIVN Harvard Medical School AIDS Initiative in Vietnam.
HIV related Opportunistic Diseases HIV related Opportunistic Diseases M.MEIDANI,MPH.MD.
Clinical Care of HIV, AIDS and Opportunistic Infections
1 Starting ART in the Context of Opportunistic Infections HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Connie van Marrewijk IDA Foundation Product Selection for Opportunistic Infections.
HIV/AIDS. Human Immunodeficiency Virus  Virus attacks the immune system  Invades and destroys certain white blood cells  Takes time for the HIV to.
Slow Acting Anti-inflammatory Drugs ). BY PROF. AZZA EL-MEDANY DR. OSAMA YOUSF.
Stage 1: Primary HIV Infection This stage of infection lasts a few weeks and feels like the flu. During this stage there is a large amount of HIV in the.
1 HIV Clinical Staging HAIVN Harvard Medical School AIDS Initiative in Vietnam.
AIDS Dr. Gerrard Uy. AIDS Definition: – According to the CDC classification system, any HIV infected individual with a CD4 T cell count of
Primary Impression. Active Pulmonary TB and Gastrointestinal tuberculosis previous history of TB – No sputum AFB smear was done to see if the patient.
AIDS Dr. Meg-angela Christi Amores. AIDS Etiologic agent: – HIV (Human Immunodeficiency Virus) – 2 types: HIV 1 and HIV 2 – Most common cause: HIV 1.
Prophylaxis of Opportunistic Infections
HIV and AIDS PM2 PATHOPHYSIOLOGY. HIV is the causative agent of AIDS Human immunodeficiency virus Human immunodeficiency virus retrovirus retrovirus most.
Human Immunodeficiency Virus & Acquired Immunodeficiency Syndrome Community Medicine - Reporting October 10, 2011.
Questions, Answers, and Explanations Infectious Diseases Blueprint.
Hematology and Hematologic Malignancies
Extrapulmonary tuberculosis and HIV Outi Vehviläinen, MD Ilembula Lutheran Hospital
29-1 A Human Perspective HIV Disease and Complications of Immunodeficiency Eugene Nester Denise Anderson Evans Roberts, Jr. Nancy Pearsall Martha Nester.
Interventions for Clients with HIV/AIDS and Other Immunodeficiencies.
Syndrome Acquired Immune Deficiency. AIDS is caused by a virus called HIV.
Chapter 5: The Medical Side of Living with HIV/AIDS.
Treatment and Prevention of Opportunistic Infections: Options for the Caribbean Region Jonathan E. Kaplan, M.D.
DR.S. MANSORI INFECTIOUS DISEASE SPECIALIST QAZVIN UNIVERCITY OF MEDICAL SCIENCE.
Chapter 11 Lymphatic System Disorders Mitzy D. Flores, MSN, RN.
Chapter 2: The Path from HIV to AIDS
HIV / AIDS HUMAN IMMUNODEFICIENCY Virus (HIV) ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
HIV/AIDS Review.
Adapted from curriculum by Tucson Interfaith HIV/AIDS Network
101, Prevention, Stages, & Treatment
PAEDIATRIC AIDS ¨     Acquired immunodeficiency Syndrome (AIDS) is caused by Human Immunodeficiency Virus type 1 and 2 ¨     World wide problem, more.
AIDS Dr. Amitabha Basu MD.
CLINICAL MANIFESTATIONS OF HIV
Management of Immune Reconstitution Inflammatory Syndrome (IRIS)
Presentation transcript:

Homework # 2 A2 Subsection Dr. Sandra Navarra USTFMS

2. Classification of HIV and Expanded AIDS Surveillance Case Definition

Category A consists of one or more of the conditions listed below in an adolescent or adult (greater than or equal to 13 years) with documented HIV infection. Conditions listed in Categories B and C must not have occurred. – Asymptomatic HIV infection – Persistent generalized lymphadenopathy – Acute (primary) HIV infection with accompanying illness or history of acute HIV infection

Category B Category B consists of symptomatic conditions in an HIV-infected adolescent or adult that are not included among conditions listed in clinical Category C. Shouldmeet at least one of the following criteria – the conditions are attributed to HIV infection or are indicative of a defect in cell-mediated immunity – the conditions are considered by physicians to have a clinical course or to require management that is complicated by HIV infection. Conditions in clinical Category B include, but are not limited to: – Bacillary angiomatosis – Candidiasis, oropharyngeal (thrush) – Candidiasis, vulvovaginal; persistent, frequent, or poorly responsive to therapy – Cervical dysplasia (moderate or severe)/cervical carcinoma in situ – Constitutional symptoms, such as fever (38.5 C) or diarrhea lasting greater than 1 month – Hairy leukoplakia, oral – Herpes zoster (shingles), involving at least two distinct episodes or more than one dermatome – Idiopathic thrombocytopenic purpura – Listeriosis – Pelvic inflammatory disease, particularly if complicated by tubo-ovarian abscess – Peripheral neuropathy

Category C includes the clinical conditions listed in the AIDS surveillance case definition. Once a Category C condition has occurred, the person will remain in Category C

Category C conditions Candidiasis of bronchi, trachea, or lungs Candidiasis, esophageal Cervical cancer, invasive * Coccidioidomycosis, disseminated or extrapulmonary Cryptococcosis, extrapulmonary Cryptosporidiosis, chronic intestinal (greater than 1 month's duration) Cytomegalovirus disease (other than liver, spleen, or nodes) Cytomegalovirus retinitis (with loss of vision) Encephalopathy, HIV-related

Category C Conditions Herpes simplex: chronic ulcer(s) (greater than 1 month's duration); or bronchitis, pneumonitis, or esophagitis Histoplasmosis, disseminated or extrapulmonary Isosporiasis, chronic intestinal (greater than 1 month's duration) Kaposi's sarcoma Lymphoma, Burkitt's (or equivalent term) Lymphoma, immunoblastic (or equivalent term) Lymphoma, primary, of brain Mycobacterium avium complex or M. kansasii, disseminated or extrapulmonary Mycobacterium tuberculosis, any site (pulmonary * or extrapulmonary) Mycobacterium, other species or unidentified species, disseminated or extrapulmonary Pneumocystis carinii pneumonia Pneumonia, recurrent * Progressive multifocal leukoencephalopathy Salmonella septicemia, recurrent Toxoplasmosis of brain Wasting syndrome due to HIV

3. List possible conditions to explain this patient’s cervical lymphadenopathy. HIV infection Kaposi's sarcoma Tuberculosis Multicentric Castleman’s disease Lymphoma Toxoplasmosis Cryptococcus Bacillary angiomatosis Cytomegalovirus infection

3. List possible conditions to explain this patient’s cervical lymphadenopathy. a. HIV infection – Disorders of the hematopoietic system including lymphadenopathy are common throughout the course of HIV infection and may be the direct result of HIV, manifestations of secondary infection or neoplasms. – Persistent generalized lymphadenopathy serve as its early clinical manifestation. – This condition is defined as the presence of enlarged lymph nodes (>1cm) in two or more extrainguinal sites for >3 months without an obvious cause – The lymphadenopathy is due to marked follicular hyperplasia in the node in response to HIV infection

3. List possible conditions to explain this patient’s cervical lymphadenopathy. a. HIV infection – In HIV patients with CD4+ T cell counts > 200/uL, the differential diagnosis of lymphadenopathy includes Kaposi sarcoma, tuberculosis, castleman’s disease and lymphoma. – In HIV patients with more advanced disease, lymphadenopathy may also be due to toxoplasmosis, systemic fungal infection or bacillary angiomatosis.

3. List possible conditions to explain this patient’s cervical lymphadenopathy. b. Kaposi sarcoma Immunocompromised patients with HHV-8 infection may present with fever, splenomegaly, lymphoid hyperplasia, pancytopenia or rapid onset KS. c. Tuberculosis Lymphadenopathy is the most common presentation of extrapulmonary TB which occurs more commonly in immuno-compromised patients especially those infected with HIV due to the impaired cell-mediated immunity essential for defense against TB.

3. List possible conditions to explain this patient’s cervical lymphadenopathy. d. Multicentric Castleman’s disease - abnormal overgrowth of lymph nodes with high fevers, anemia, weight loss, loss of appetite, and low white blood cell counts due to the overproduction of interleukin 6. e. Lymphoma - higher incidence among HIV patients characterized by lymphadenopathy, fever of unknown origin, weight loss, pruritus, anorexia, fatigue

3. List possible conditions to explain this patient’s cervical lymphadenopathy. f. Toxoplasmosis - a parasitic disease caused by Toxoplasma gondii presenting with swollen lymph nodes, or muscle aches and pains that last for a month or more. Immunocompromised patients, such as those with HIV/AIDS may develop severe toxoplasmosis which can cause damage to the brain (encephalitis) or the eyes (necrotizing retinochoroiditis). g. Cryptococcus infection - most commonly present with meningoencephalitis, headache, nausea, dementia, irritability caused by Cryptococcus neoformans

3. List possible conditions to explain this patient’s cervical lymphadenopathy. h. Bacillary angiomatosis - characterized by the proliferation of blood vessels, resulting in tumour-like masses in the skin and other organs (lymph nodes, brain, bone marrow, spleen, liver) caused by Bartonella henselae or Bartonella quintana i. Cytomegalovirus infection - CMV is an important pathogen when CD4+ cell counts fall below /uL, producing lymphadenopathy, retinitis, colitis, and disseminated disease.

4. Enumerate rheumatologic conditions in HIV-infected individuals

HIV-associated Rheumatic Diseases disorders of the joints and muscles that can result from the HIV infection. Painful joints and muscles are usually the first and most common complaints. HIV-associated Rheumatic Diseases are: Reactive arthritis – Reiter’s syndrome, Psoriatic Arthritis HIV-associated arthropathy Painful articular syndrome Diffuse infiltrative lymphocytosis syndrome (DILS) Fibromyalgia, septic arthritis, vasculitis Reference: Fauci. Braunwald. Kasper. Hauser. Longo. Jameson. Loscalzo Harrison’s Principles of Internal Medicine, 17 th Edition. McGraw-Hill. USA

Reiter’s Syndrome a triad of arthritis, urethritis & conjunctivitis usually develops following an intestinal or a genital/urinary tract infection Psoriatic Arthritis type of inflammatory arthritis that affects 10-30% of people suffering from the chronic skin condition psoriasis exact cause unknown; genetic cause? Reference: Fauci. Braunwald. Kasper. Hauser. Longo. Jameson. Loscalzo Harrison’s Principles of Internal Medicine, 17 th Edition. McGraw-Hill. USA

Reiter’s Syndrome & Psoriatic Arthritis Occur with increasing frequency as the competency of the immune system declines Related to an increase in infections with organisms that trigger a reactive arthritis with progressive immunodeficiency or to a loss of important regulatory T cells. Reference: Fauci. Braunwald. Kasper. Hauser. Longo. Jameson. Loscalzo Harrison’s Principles of Internal Medicine, 17 th Edition. McGraw-Hill. USA

HIV-associated Arthropathy Characterized by subacute oligoarticular arthritis developing over a period of 1-6 weeks and lasting 6 weeks to 6 months Generally involves the larger joints (knees and ankles) Non-erosive with only a mild inflammatory response NSAIDs are marginally helpful Intra-articular glucocorticoids have been more useful in pain relief Reference: Fauci. Braunwald. Kasper. Hauser. Longo. Jameson. Loscalzo Harrison’s Principles of Internal Medicine, 17 th Edition. McGraw-Hill. USA

Painful Articular Syndrome 10% of AIDS patients Presents as acute severe sharp pain in the affected joint (knees, elbows and shoulders) Episodes last 2-24 hrs Cause is unclear; however, it may be a result from a direct effect of HIV on the joint. Condition is reminiscent of the fact that other lentiviruses (caprine arthritis-encephalitis virus) are capable of causing arthritis Reference: Fauci. Braunwald. Kasper. Hauser. Longo. Jameson. Loscalzo Harrison’s Principles of Internal Medicine, 17 th Edition. McGraw-Hill. USA

Diffuse Infiltrative Lymphocytosis Syndrome (DILS) Autoimmune disease that occurs with an increased frequency in HIV patients Parotid gland enlargement, dry eyes, dry mouth associated with lymphocytic infiltrates of the salivary gland and lung Infiltrates predominantly CD8+ T cells Reference: Fauci. Braunwald. Kasper. Hauser. Longo. Jameson. Loscalzo Harrison’s Principles of Internal Medicine, 17 th Edition. McGraw-Hill. USA

Other Rheumatologic Disorders associated with HIV Patients There have been reports of leukocytoclastic vasculitis in the setting of zidovudine therapy. CNS angiitis and polymyositis have also been reported. Septic arthritis = due to S. aureus, systemic fungal infections Reference: Fauci. Braunwald. Kasper. Hauser. Longo. Jameson. Loscalzo Harrison’s Principles of Internal Medicine, 17 th Edition. McGraw-Hill. USA

5. Describe the features/treatment of TB in the HIV patient, which may differ from that in a non-HIV patient

TB in an HIV Patient A new TB infection acquired by an HIV infected patient may evolve to active disease in weeks rather than months or years. When CMI is only partially compromised, pulmonary tuberculosis presents in a typical manner. In late stages of HIV infection, a primary tuberculosis-like pattern, with diffuse interstitial or miliary infiltrates, little or no cavitation, and intrathoracic lymphadenopathy is more common. Sputum smears may be positive less frequently.

TB in an HIV Patient Extrapulmonary TB is more common (lymphatic, disseminated, pleural and pericardial are the most common) Atypical radiographic findings, lack of classic granuloma formation in late stages, negative TST.

Treatment Regimen

Treatment Standard treatment are equally efficacious, with more pronounced adverse effects. Increased frequency of drug interactions between antiretroviral therapy and rifamycins Development of of Rifampin monoresistance. Substitute rifabutin to rifampin.

6. Indications for initiation of anti-retroviral therapy in patients with HIV infection Therapy should be initiated in patients with a CD4 count of <200 cells/microliter or in the symptomatic patient (with AIDS, thrush, or unexplained fever) regardless of the CD4 count or viral load. In the asymptomatic patient, if the CD4 count is between 200 and 350 cells/microliter, initiation or ART is recommended, although some controversy still exists. Initiation of ART depends on the patient’s readiness, comorbidities, and drug toxicities.

6. Indications for initiation of anti- retroviral therapy in patients with HIV infection In the asymptomatic patient, if the HIV RNA is >100,000 copies/ml, initiation of the highly reactive ART is recommended although some controversy exists. Initiation of ART depends on the patient’s readiness, comorbidities, and drug toxicities.